Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study-Reference-Cited by-同舟云学术

Serum levels of interleukin-22, cardiometabolic risk factors and incident type 2 diabetes: KORA F4/FF4 study

Published:2017-01-31 Issue:1 Volume:16 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Herder Christian^ORCID,Kannenberg Julia M.,Carstensen-Kirberg Maren,Huth Cornelia,Meisinger Christa,Koenig Wolfgang,Peters Annette,Rathmann Wolfgang,Roden Michael,Thorand Barbara

Funder

German Federal Ministry of Education and Research

State of Bavaria

Ministry of Science and Research of the State of North Rhine-Westphalia

German Federal Ministry of Health

German Research Foundation

German Center for Diabetes Research

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12933-017-0498-6.pdf

Reference28 articles.

1. Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines—from host defence to tissue homeostasis. Nat Rev Immunol. 2014;14:783–95.

2. Dudakov JA, Hanash AM, van den Brink MR. Interleukin-22: immunobiology and pathology. Annu Rev Immunol. 2015;33:747–85.

3. Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, Tardif MR, Sathaliyawala T, Kubota M, Farber DL, Collman RG, Shaked A, Fouser LA, Weiner DB, Tessier PA, Friedman JR, Kiyono H, Bushman FD, Chang KM, Artis D. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science. 2012;336:1321–5.

4. Wang X, Ota N, Manzanillo P, Kates L, Zavala-Solorio J, Eidenschenk C, Zhang J, Lesch J, Lee WP, Ross J, Diehl L, van Bruggen N, Kolumam G, Ouyang W. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature. 2014;514:237–41.

5. Hasnain SZ, Borg DJ, Harcourt BE, Tong H, Sheng YH, Ng CP, Das I, Wang R, Chen AC, Loudovaris T, Kay TW, Thomas HE, Whitehead JP, Forbes JM, Prins JB, McGuckin MA. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nat Med. 2014;20:1417–26.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of combustible cigarettes and electronic nicotine delivery systems on immune cell‐driven inflammation: Evidences from diabetic patients and multiple low dose streptozotocin‐treated diabetic mice;Journal of Biochemical and Molecular Toxicology;2024-09

2. Hyperuricemia, gout and digestive system pathology: common links of pathogenesis;Experimental and Clinical Gastroenterology;2024-03-26

3. Distinctive Signs of Disease as Deterrents for the Endothelial Function: A Systematic Review;Metabolites;2023-03-16

4. Obesity, Lipid Profile and Cytokines in Spondyloarthritis;Indian Journal of Endocrinology and Metabolism;2022-07

5. Association of C-Terminal Pro-Endothelin-1 with Mortality in the Population-Based KORA F4 Study;Vascular Health and Risk Management;2022-05